$FATE

$2.27▲ -0.9% YTD

5 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

News

FATE ▼ -0.9% - Fate Therapeutics, Inc.

CP $2.27▲ -0.9%Oct 2, 2026 · ThinkSabio Blog

$FATE - Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)…

News

FATE ▲ +0.8% - Fate Therapeutics, Inc.

CP $2.40▲ +0.8%Oct 1, 2026 · ThinkSabio Blog

$FATE - Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences…

News

FATE ▼ -2.5% - Fate Therapeutics, Inc.

CP $2.30▲ -2.5%Sep 16, 2026 · ThinkSabio Blog

$FATE - Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence…

News

FATE ▲ +0.4% - Fate Therapeutics, Inc.

CP $2.50▲ +0.4%Sep 9, 2026 · ThinkSabio Blog

$FATE - Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeti…

SEC 13D/G

$FATE SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified

$2.85▲ 187.88%Jul 8, 2026 · ThinkSabio Blog

$FATE SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #FATE : $2.85 Sector: Healthcare | YTD: 🔼+ 187.88% The SEC discl…